Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT04040205
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Chondrosarcoma
- Osteosarcoma
- Soft Tissue Sarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Abemaciclib — DRUGAbemaciclib 200 mg will be taken by mouth twice daily.
Study Details
This is a single-arm, phase II study that will enroll a total of 45 subjects. All subjects will have a confirmed diagnosis of metastatic or unresectable soft tissue sarcoma or bone sarcoma. All subjects must have intact Rb, identified at the time of screening, by immunohistochemistry testing of submitted tumor specimen. Subjects will receive Abemaciclib 200 mg twice daily until progression or discontinuation criteria are met.
Key Dates
- Start date
- Oct 7, 2019
- Status verified
- Jul 2025
- Primary completion
- Jun 1, 2027
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 44 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: AbemaciclibSubjects will be treated with abemaciclib 200 mg twice daily by mouth.
Primary Outcome Measure
Progression-free survival [ Time Frame: 12 weeks ]
Central Contacts
- Medical College of Wisconsin Cancer Center Clinical Trials Office866-680-0505
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | Steven Attia, DO |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | |
| Washington University in St. Louis | St Louis | Missouri | 63130 | Brian Van Tine, MD (PRINCIPAL_INVESTIGATOR) |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | John Charlson, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruiting · Children's Oncology Group · Birmingham, Alabama
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsPHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California